A carregar...
Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
Introduction: High-risk patients with grade 3 endometrioid endometrial carcinoma (G3EEC) who require adjuvant therapy have not been clearly identified. Therefore, the current study aimed to investigate the prognostic impact of ARID1A, p53, and mismatch repair (MMR) protein expressions, previously re...
Na minha lista:
| Publicado no: | Pathol Oncol Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262237/ https://ncbi.nlm.nih.gov/pubmed/34257552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.598550 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|